In future, Stefan H.E. Kaufmann's Emeritus Group will mainly focus on bioinformatics analyses in systems immunology. In particular, bioinformatics will be used to predict the safety and protective effects of vaccines and the risk of disease in infected persons. This topic covers the terms:
- Systems biology of tuberculosis
- Systems vaccinology
- Rational design of a vaccine against tuberculosis
- Biomarkers of susceptibility/resistance in tuberculosis
Press releases and research news
VPM1002, developed by Emeritus Director Stefan H.E. Kaufmann and his team, has also fewer side effects compared to BCG, the only vaccine available to date o prevent tuberculosis .
Together with his team, Stefan H. E. Kaufmann has advanced the development of a new vaccine against tuberculosis, which could also serve as an interim solution for Covid-19. The infection biologist will continue his research with an emeritus group in Göttingen.